SPDR S&P Biotech shares owned by Doliver Capital Advisors
Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Doliver Capital Advisors
from 13F filings
Historical chart of Doliver Capital Advisors investment in SPDR S&P Biotech
Tip: Access up to 7 years of quarterly data
All positions including SPDR S&P Biotech held by Doliver Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SPDR S&P Biotech by Doliver Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $316k | 3.2k | 100.20 |
| 2025-06-30 | $268k | 3.2k | 82.93 |
| 2025-03-31 | $262k | 3.2k | 81.10 |
| 2024-12-31 | $298k | 3.3k | 90.06 |
| 2024-09-30 | $332k | 3.4k | 98.80 |
| 2024-06-30 | $321k | 3.5k | 92.71 |
| 2024-03-31 | $224k | 2.4k | 94.89 |
| 2023-12-31 | $215k | 2.4k | 89.29 |
| 2023-06-30 | $211k | 2.5k | 83.20 |
| 2023-03-31 | $207k | 2.7k | 76.21 |
| 2022-12-31 | $259k | 3.1k | 83.00 |
| 2022-09-30 | $249k | 3.1k | 79.30 |
| 2022-06-30 | $277k | 3.7k | 74.32 |
| 2022-03-31 | $296k | 3.3k | 89.97 |